Literature DB >> 25470742

Stage IB2 adenosquamous cervical cancer diagnosed at 19-weeks' gestation.

Luiza D Peculis1, Yvette Ius, Michael Campion, Michael Friedlander, Neville Hacker.   

Abstract

Neoadjuvant chemotherapy (NACT) for advanced cervical cancer in pregnancy has been shown to increase operability and be effective against spread of disease. In all reported cases of advanced disease, residual tumour has been found at surgery following NACT. We present a case of a 27-year old diagnosed with stage IB2 adenosquamous cervical carcinoma at 19-weeks' gestation who was treated with NACT. Following caesarean section and radical hysterectomy, histopathology showed no evidence of residual tumour in the cervix and negative pelvic lymph nodes.
© 2014 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  cervical cancer; neoadjuvant chemotherapy; pregnancy

Mesh:

Year:  2014        PMID: 25470742     DOI: 10.1111/ajo.12281

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  3 in total

1.  Neoadjuvant chemotherapy with paclitaxel plus cisplatin before radical surgery for locally advanced cervical cancer during pregnancy: A case series and literature review.

Authors:  Huiqiong Huang; Yi Quan; Xiaorong Qi; Ping Liu
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

2.  Treatment and clinical outcomes of cervical cancer during pregnancy.

Authors:  Jing Ma; Lan Yu; Fan Xu; Hongyan Yi; Wenfei Wei; Peng Wu; Sha Wu; Hua Li; Hong Ye; Wei Wang; Hui Xing; Liangsheng Fan
Journal:  Ann Transl Med       Date:  2019-06

3.  Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis.

Authors:  Yizuo Song; Yi Liu; Min Lin; Bo Sheng; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2018-12-19       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.